Comprehensive Geriatric Assessment in the Elderly Subjects (PROMISING)
NCT ID: NCT05822154
Last Updated: 2023-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2022-10-03
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comprehensive Validation of Frailty Assessment Tools in Older Adults in Different Clinical and Social Settings
NCT02637518
Comprehensive Geriatric Assessment in the Emergency Department
NCT05252182
Development of General Practitioners Screening Tool of Frail Older Old Community
NCT02087982
Epidemiological Observatory on the Health Conditions of Inpatients Aged 65 or Older at the INRCA Research Hospitals
NCT01397682
Application of Frailty Prevention Care Management Program of Community Elderly Adults
NCT05883423
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
elderly subjects
subjects aged 65 years and over
comprehensive geriatric assessment
The clinical, biological and functional characteristics will be collected in elderly subjects attending the hospitals of participating centers.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
comprehensive geriatric assessment
The clinical, biological and functional characteristics will be collected in elderly subjects attending the hospitals of participating centers.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, Italy
OTHER_GOV
Istituto Nazionale di Ricovero e Cura per Anziani
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrea Corsonello, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS INRCA, Cosenza, Italy
Simona Ciccone, MD
Role: PRINCIPAL_INVESTIGATOR
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
Antonio Greco, MD
Role: PRINCIPAL_INVESTIGATOR
Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
Rodolfo Sardone, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS "Saverio de Bellis", Castellana Grotte (BA), Italy
Fabrizio Giunco, MD
Role: PRINCIPAL_INVESTIGATOR
Fondazione Don Carlo Gnocchi, Milano, Italy
Mariacristina Parravano, MD
Role: PRINCIPAL_INVESTIGATOR
Fondazione G.B. Bietti per lo Studio e la Ricerca in Oftalmologia, Roma, Italy
Marco Lenti, MD
Role: PRINCIPAL_INVESTIGATOR
Fondazione Policlinico San Matteo, Pavia, Italy
Rosa Liperoti, MD
Role: PRINCIPAL_INVESTIGATOR
Fondazione Policlinico Universitario A. Gemelli, Roma, Italy
Francesca Bruni, MD
Role: PRINCIPAL_INVESTIGATOR
Istituto Auxologico Italiano, Milano, Italy
Giuseppe Rengo, MD
Role: PRINCIPAL_INVESTIGATOR
Istituti Clinici Scientifici Maugeri, Scientific Institute of Telese Terme (BN), Italy
Milena Fini, MD
Role: PRINCIPAL_INVESTIGATOR
Istituto Ortopedico Rizzoli, Bologna, Italy
Luigi Zagra, MD
Role: PRINCIPAL_INVESTIGATOR
Istituto Ortopedico Galeazzi, Milano, Italy
Alessandro Nobili, MD
Role: PRINCIPAL_INVESTIGATOR
Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
IRCCS INRCA Hospital
Cosenza, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INRCA_001_2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.